The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells
The proton pump inhibitor lansoprazole inhibits rhinovirus infection in cultured human tracheal epithelial cells
复制标题
DOI:
10.1016/j.ejphar.2004.12.042
复制
发表时间:
2005-02-21
影响因子:
5
通讯作者:
Sasaki, H
中科院分区:
文献类型:
--
作者:
Sasaki, T;Yamaya, M;Sasaki, H
To examine the effects of lansoprazole, a proton pump inhibitor, on rhinovirus infection in airways, human tracheal epithelial cells were infected with a major subgroup of rhmoviruses, type 14 rhinovirus. Rhinovirus increased the mRNA expression of intercellular adhesion molecule-1 (ICAM-1) in the cells, the major rhinovirus receptor, and the content of the soluble form of ICAM- 1 (sICAM-1) and cytokines in supernatants. Lansoprazole reduced supernatant titers and RNA of rhinovirus, the susceptibility to rhinovirus infection, the ICAM-1 mRNA production, the number and fluorescence intensity of acidic endosomes in the cells, and supernatants sICAM-1 and cytokine concentrations including interleukin-1beta. Antibody to interleukin-1beta reduced baseline and rhinovirus-induced ICAM- 1 production. These results suggest that lansoprazole inhibits rhinovirus infection by reducing ICAM-1 via partly endogenous production of interleukin-1, and by blocking the rhinovirus RNA entry into the endosomes. Lansoprazole may modulate airway inflammation by reducing the production of cytokines and ICAM-1 in rhinovirus infection. (C) 2004 Elsevier B.V. All rights reserved.